The risk or severity of adverse effects can be increased when Olmesartan is combined with Telmisartan. Methylphenidate may decrease the antihypertensive activities of Telmisartan. Telmisartan may increase the hypotensive activities of Xylometazoline. Mirodenafil may increase the antihypertensive activities of Telmisartan. Yohimbine may decrease the antihypertensive activities of Telmisartan. The serum concentration of Digitoxin can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Acetylsalicylic acid. Selegiline may increase the hypotensive activities of Telmisartan. Trans-2-Phenylcyclopropylamine may increase the hypotensive activities of Telmisartan. Ketanserin may increase the hypotensive activities of Telmisartan. Sildenafil may increase the antihypertensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Lumiracoxib. Telmisartan may increase the hypotensive activities of Tibolone. The serum concentration of Rifaximin can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Floctafenine. Thiopental may increase the hypotensive activities of Telmisartan. Telmisartan may increase the hypotensive activities of Manidipine. The risk or severity of adverse effects can be increased when Valsartan is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Nebivolol. The risk or severity of adverse effects can be increased when Rotigotine is combined with Telmisartan. Avanafil may increase the antihypertensive activities of Telmisartan. Fenoldopam may increase the hypotensive activities of Telmisartan. Telmisartan may increase the hypotensive activities of Rituximab. The risk or severity of adverse effects can be increased when Nisoldipine is combined with Telmisartan. Telmisartan may increase the orthostatic hypotensive activities of Levodopa. The risk or severity of adverse effects can be increased when Telmisartan is combined with Higenamine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Meclofenamic acid. The risk or severity of adverse effects can be increased when Timolol is combined with Telmisartan. The risk or severity of adverse effects can be increased when Nabilone is combined with Telmisartan. The risk or severity of adverse effects can be increased when Tretinoin is combined with Telmisartan. Telmisartan may increase the hypotensive activities of Pentolinium. The risk or severity of adverse effects can be increased when Telmisartan is combined with Salicylamide. Telmisartan may increase the hypotensive activities of Lacidipine. The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Telmisartan. The risk or severity of adverse effects can be increased when Betaxolol is combined with Telmisartan. The serum concentration of Everolimus can be increased when it is combined with Telmisartan. Tadalafil may increase the antihypertensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Sulindac. The risk or severity of adverse effects can be increased when Telmisartan is combined with Tranilast. Telmisartan may increase the hypotensive activities of Amifostine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Nadolol. The risk or severity of adverse effects can be increased when Telmisartan is combined with Lornoxicam. The risk or severity of adverse effects can be increased when Telmisartan is combined with Nesiritide. The risk or severity of adverse effects can be increased when Telmisartan is combined with Kebuzone. The serum concentration of Oleandrin can be increased when it is combined with Telmisartan. The serum concentration of Ouabain can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Lisofylline. Dorzolamide may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Indobufen. Methylphenobarbital may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Pimecrolimus. The risk or severity of adverse effects can be increased when Telmisartan is combined with Olsalazine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Dipyridamole. The risk or severity of adverse effects can be increased when Telmisartan is combined with Isoxsuprine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Seratrodast. The risk or severity of adverse effects can be increased when Telmisartan is combined with Choline magnesium trisalicylate. The risk or severity of adverse effects can be increased when Telmisartan is combined with Carbaspirin calcium. The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Felodipine. The serum concentration of Digoxin can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Atenolol is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Ketorolac. Telmisartan may increase the hypotensive activities of Risperidone. The risk or severity of adverse effects can be increased when Paclitaxel is combined with Telmisartan. Aliskiren may increase the hyperkalemic activities of Telmisartan. Brimonidine may increase the antihypertensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Diltiazem is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Diflunisal. Ardeparin may increase the hyperkalemic activities of Telmisartan. Telmisartan may increase the hypotensive activities of Talinolol. The risk or severity of adverse effects can be increased when Telmisartan is combined with E-6201. The therapeutic efficacy of Telmisartan can be decreased when used in combination with Acemetacin. The risk or severity of adverse effects can be increased when Telmisartan is combined with Diclofenac. The risk or severity of adverse effects can be increased when Telmisartan is combined with Mizoribine. The serum concentration of Bosutinib can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Curcumin. The risk or severity of adverse effects can be increased when Clofarabine is combined with Telmisartan. Pargyline may increase the hypotensive activities of Telmisartan. Telmisartan may increase the hypotensive activities of Cyclopenthiazide. The risk or severity of adverse effects can be increased when Tizanidine is combined with Telmisartan. The risk or severity of adverse effects can be increased when Amlodipine is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Etanercept. Telmisartan may increase the hypotensive activities of Indenolol. Telmisartan may increase the hypotensive activities of BQ-123. Telmisartan may increase the hypotensive activities of Bepridil. Iproclozide may increase the hypotensive activities of Telmisartan. Nicorandil may increase the hypotensive activities of Telmisartan. Telmisartan may increase the hypotensive activities of Naftopidil. Pheniprazine may increase the hypotensive activities of Telmisartan. Amphetamine may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Serrapeptase. The serum concentration of Proscillaridin can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Etoricoxib. Telmisartan may increase the hypotensive activities of Vinpocetine. Bimatoprost may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Streptokinase is combined with Telmisartan. The risk or severity of adverse effects can be increased when Indapamide is combined with Telmisartan. Caroxazone may increase the hypotensive activities of Telmisartan. Mebanazine may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Telmisartan. Heparin may increase the hyperkalemic activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Clonixin. Pirlindole may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Amiodarone is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Bufexamac. The risk or severity of adverse effects can be increased when Telmisartan is combined with Nepafenac. The risk or severity of adverse effects can be increased when Telmisartan is combined with Etofenamate. The risk or severity of adverse effects can be increased when Telmisartan is combined with Lisinopril. The risk or severity of adverse effects can be increased when Telmisartan is combined with Rofecoxib. The risk or severity of adverse effects can be increased when Tamsulosin is combined with Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Ibuproxam. Toloxatone may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Meloxicam. The risk or severity of adverse effects can be increased when Telmisartan is combined with Antipyrine. The serum concentration of Ranolazine can be increased when it is combined with Telmisartan. The serum concentration of Colchicine can be increased when it is combined with Telmisartan. The risk or severity of adverse effects can be increased when Tolcapone is combined with Telmisartan. Methohexital may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Azilsartan medoxomil. The risk or severity of adverse effects can be increased when Esmolol is combined with Telmisartan. Urapidil may increase the hypotensive activities of Telmisartan. The risk or severity of adverse effects can be increased when Telmisartan is combined with Papaverine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Loxoprofen. The risk or severity of adverse effects can be increased when Telmisartan is combined with Benzydamine. The risk or severity of adverse effects can be increased when Telmisartan is combined with Quinapril. The risk or severity of adverse effects can be increased when Telmisartan is combined with Leflunomide. The risk or severity of adverse effects can be increased when Telmisartan is combined with Teriflunomide. The serum concentration of Prucalopride can be increased when it is combined with Telmisartan. Telmisartan may increase the hypotensive activities of Ambrisentan.